Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,182 across all filing types
Latest filing 2021-03-24 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
LupinLife Partners with Uttarakhand Police to Promote Hand Hygiene at Kumbh Mela 2021.
Regulatory Filings
2021-03-24 English
Scrutiniser''s Report for declaration of Postal Ballot Results.
Regulatory Filings
2021-03-17 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Scrutiniser's Report for Postal Ballot' and details the results of voting on several resolutions related to the appointment of independent directors. It includes vote counts, percentages, and confirms the passing of these resolutions. The document is a formal report on the outcome of shareholder voting conducted via postal ballot and e-voting. It is not an announcement of a report publication, nor is it a financial report or management discussion. It is also not a proxy solicitation or AGM presentation. The content fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially declares the results of shareholder votes at a general meeting conducted by postal ballot.
2021-03-17 English
Lupin Launches Authorized Generic Version of Alinia®.
Regulatory Filings
2021-03-10 English
Press Release
Capital/Financing Update Classification · 85% confidence The document is a press release announcing the launch of an authorized generic version of a pharmaceutical product by Lupin Limited. It is addressed to stock exchanges as a disclosure pursuant to SEBI regulations. The content focuses on product launch information and company background, without any financial statements, detailed financial performance, or regulatory filings. The document length is 3560 characters, which is relatively short and primarily an announcement rather than a detailed report. It does not contain financial results, management discussion, or audit information. Therefore, it fits best as a Capital/Financing Update (CAP) since it relates to a significant business development that could impact the company's market position and potentially its capital markets perception, but it is not a financial report or earnings release.
2021-03-10 English
Lupin Pharma Canada Announces Partnership with Endoceutics for the commercialization of Intrarosa®.
Regulatory Filings Classification · 100% confidence The document is a regulatory filing submitted to the BSE and NSE in India pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It serves as a formal announcement of a partnership between Lupin Pharma Canada and Endoceutics to commercialize a product. As it is a general regulatory announcement regarding corporate developments that does not fit into specific financial report categories, it is classified as a Regulatory Filing (RNS).
2021-03-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.